Sensipar News
Most Popular Sensipar Story
Amgen sues Barr over generic Sensipar
Barr Pharmaceuticals Inc. confirmed that its subsidiary, Barr Laboratories Inc., will go head to head with Amgen in a patent challenge process under the Hatch-Waxman Act. Brigham and Women's Hospital Read more...
Latest Headlines
- July 28, 2010
- July 30, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
